Skip to main content

A Proposal and Challenge for Proponents and Skeptics of Psi

πŸ“„ Original study β†—
Kennedy, J.E β€’ 2004 Modern Era β€’ methodology

πŸ“Œ Appears in:

Plain English Summary

Years before pre-registration became a buzzword in science, Kennedy proposed something bold: treat psi research the way we treat drug trials. He pointed out a damning pattern in psi meta-analyses -- 70-80% of the individual studies pooled together were actually non-significant, and bigger studies weren't producing stronger statistical signals, which breaks a basic rule of how statistical evidence should work. His fix? Assemble a mixed committee of believers, moderate skeptics, and statisticians to agree on study designs before running them. Then he threw down a double challenge: skeptics must say what evidence would convince them, and proponents must show their effects are reliable enough to survive such planning. It was a remarkably fair gauntlet that anticipated where all of science eventually headed.

Actual Paper Abstract

Pharmaceutical research provides a useful model for doing convincing research in situations with intense, critical scrutiny of studies. The protocol for a "pivotal" study that is used for decision-making is reviewed by the FDA before the study is begun. The protocol is expected to include a power analysis demonstrating that the study has at least a .8 probability of obtaining significant results with the anticipated effect size, and to specify the statistical analysis that will determine the success of the experiment, including correction for multiple analyses. FDA inspectors often perform audits of the sites where data are collected and/or processed to verify the raw data and experimental procedures. If parapsychological experiments are to provide convincing evidence, power analyses should be done at the planning stage. A committee of experienced parapsychologists, moderate skeptics, and a statistician could review and comment on protocols for proposed "pivotal" studies in an effort to address methodological issues before rather than after the data are collected. The evidence that increasing sample size does not increase the probability of significant results in psi research may prevent the application of these methods and raises questions about the experimental approach for psi research.

Research Notes

Anticipated the pre-registration movement by nearly a decade. Central to the meta-debate controversy (#10) β€” argues that meta-analytic approaches alone cannot resolve the psi debate without prospective planning, power analysis, and agreed-upon protocols. Links Kennedy's broader research program on psi's capricious nature.

Pharmaceutical clinical trials, with FDA-mandated power analyses, pre-specified primary outcomes, and independent protocol review, offer a rigorous model for psi research trapped in cycles of inconclusive meta-analysis. Examining published psi meta-analyses reveals that 70-80% of constituent studies are non-significant and z scores fail to increase with sample size β€” violating a fundamental assumption of statistical testing. A committee of parapsychologists, moderate skeptics, and a statistician is proposed to review pivotal study protocols prospectively. Kennedy challenges skeptics to specify adequate protocols in advance and proponents to demonstrate psi effects are reliable enough for prospective planning.

Related Papers

Also by these authors

More in Methodology

πŸ“‹ Cite this paper
APA
Kennedy, J.E (2004). A Proposal and Challenge for Proponents and Skeptics of Psi. Journal of Parapsychology.
BibTeX
@article{kennedy_2004_proposal,
  title = {A Proposal and Challenge for Proponents and Skeptics of Psi},
  author = {Kennedy, J.E},
  year = {2004},
  journal = {Journal of Parapsychology},
}